View Larger Map | Get Directions
Dr. James Mohler responds to new research that supports active surveillance for low-risk prostate cancer; discourages overtreatment.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
National Cancer Institute Comprehensive Cancer CenterA Blue Distinction Center for Complex and Rare CancersNational Comprehensive Cancer NetworkANCC Magnet Recognition ProgramThe Leapfrog Group 2012 Top HospitalA Joint Commission National Quality HospitalThe Quality Oncology Practice Initiative